tiprankstipranks
HUTCHMED Secures NMPA Approval for TAZVERIK® in China
PremiumCompany AnnouncementsHUTCHMED Secures NMPA Approval for TAZVERIK® in China
1M ago
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
Premium
Ratings
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
1M ago
HUTCHMED Announces Board Changes Following Director Retirements
Premium
Company Announcements
HUTCHMED Announces Board Changes Following Director Retirements
1M ago
HUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
PremiumCompany AnnouncementsHUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
1M ago
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
Premium
The Fly
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
2M ago
HUTCHMED and Innovent’s Combination Therapy Shows Promise in Advanced Renal Cell Carcinoma
Premium
Company Announcements
HUTCHMED and Innovent’s Combination Therapy Shows Promise in Advanced Renal Cell Carcinoma
2M ago
HUTCHMED Appoints Alvin Wong as Independent Non-executive Director
PremiumCompany AnnouncementsHUTCHMED Appoints Alvin Wong as Independent Non-executive Director
2M ago
HUTCHMED Announces Major Equity Disposal in SHPL
Premium
Company Announcements
HUTCHMED Announces Major Equity Disposal in SHPL
2M ago
HUTCHMED Updates on Disposal of Shanghai Hutchison Pharmaceuticals Stake
Premium
Company Announcements
HUTCHMED Updates on Disposal of Shanghai Hutchison Pharmaceuticals Stake
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100